OrbiMed’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8.83M Hold
2025
Q1
$8.38M Hold
2024
Q4
$13.9M Hold
2024
Q3
$22.6M Hold
2024
Q2
$41.6M Hold
2024
Q1
$51.7M Hold
2023
Q4
$46.6M Hold
2023
Q3
$33.7M Hold
2023
Q2
$49.1M Buy
2023
Q1
$57.2M Hold
2022
Q4
$60.6M Hold
2022
Q3
$66.4K Hold
2022
Q2
$52.4K Hold
2022
Q1
$69.3M Hold
2021
Q4
$125M Hold
2021
Q3
$314M Hold
2021
Q2
$287M Hold
2021
Q1
$435M Sell
2020
Q4
$1.12B Hold
2020
Q3
$470M Buy